← Back to EDSA

Edesa Biotech, Inc. - Common Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 14/05/2026Dec 2025Filed 13/02/2026Jun 2025Filed 13/08/2026Mar 2025Filed 14/05/2026Dec 2024Filed 13/02/2026Jun 2024Filed 08/08/2025Mar 2024Filed 14/05/2025
−$5.4−$4.2−$2.2−$1.7−$1.6−$1.6−$1.7−$1.9
−$0.60−$0.49−$0.28−$0.25−$0.30−$0.48−$0.52−$0.58
98.5875.33.33.23.2

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.